Although MRPs are dysregulated in breast cancer patients, including the aforementioned MRPL9, MRPL12, and MRPL13, the specific mechanisms underlying the activity of these proteins in relation to this cancer have yet to be explored. Here, MRPL9 is linked to breast cancer.